Mavatrep
Mavatrep
Mavatrep (pronounced: ma-va-trep) is a non-opioid analgesic that is used for the treatment of chronic pain. It is a selective antagonist of the Transient Receptor Potential Vanilloid 1 (TRPV1) channel, which is involved in the transmission and modulation of pain.
Etymology
The term "Mavatrep" is a coined name, with no known etymology.
Mechanism of Action
Mavatrep works by selectively blocking the TRPV1 channel, which is a key player in the transmission of pain signals. By inhibiting this channel, Mavatrep can effectively reduce the perception of pain without the risk of addiction associated with opioid analgesics.
Related Terms
- Analgesic: A class of drugs that are used to relieve pain.
- Chronic Pain: A persistent or recurrent pain that lasts for more than 3 months.
- Transient Receptor Potential Vanilloid 1 (TRPV1): A type of ion channel that plays a key role in the transmission of pain signals.
- Antagonist: A substance that interferes with or inhibits the physiological action of another.
- Opioid: A class of drugs that are commonly used for their analgesic effects.
See Also
External links
- Medical encyclopedia article on Mavatrep
- Wikipedia's article - Mavatrep
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski